CLINICAL ROLE -
Trending News Today: Affordable Care Act Repeal Faces Hurdles
Top news of the day from across the healthcare landscape.
Read More
Tapping Specialty Market Potential Tops SPT Week in Review
Top articles of the week from Specialty Pharmacy Times.
Hepatitis C Eliminated Transplanted Infected Kidneys
Transplanting organs from donors infected with hepatitis C found to be a viable option.
FDA Accepts sBLA for Inflammatory Disorder Biologic
Hizentra may treat patients with chronic inflammatory demyelinating polyneuropathy.
NCPA Urges House Committee to Support Three Medicare-Strengthening Bills
Cancer Mortality High in Rural America
Rural areas have a higher rate of death for lung, colorectal, prostate, and cervical cancers.
Generic Ophthalmic Drugs Could Save Millions for Medicare
Eye care providers found to prescribe more branded drugs than any other specialty.
Rural Americans Face Higher Risk of Cancer
Cancer rates in rural America decreasing slower than urban areas.
CDC Awards $12 Million to Combat Opioid Epidemic
New initiative will help fund surveillance technology to control the rate of opioid-related overdoses.
Herpes Virus Targets Metastatic Melanomas in the Brain
Stem cells loaded with oncolytic herpes simplex virus significantly slowed tumor growth in mice.
Diabetes Linked to Changes in Oral Microbiome, Periodontitis
Type 2 diabetes can alter the oral microbiome and lead to inflammation.
FDA Works to Reduce Antibiotic Misuse, Resistance
Antibiotic-resistant bacteria causes millions of infections in the United States each year.
What Role Do Statins Play in Ovarian Cancer Treatment?
Pitavastatin may serve as a potential treatment for drug-resistant ovarian cancer.
Current Treatments Prove Effective Against MRSA Infections
High cure rates for MRSA infections observed with certain antimicrobials.
Novel Approach Can Immobilize Cancer Cells
Attacking overgrown lamellipodia and filopodia could prevent cancer metastasis.
Trending News Today: GOP Leaders Now Seeking to Repeal, Not Replace ACA
Top news of the day from across the health care landscape.
Trending News Today: HIV/AIDS Related Deaths on the Decline
Antiviral Drugs Reduce Liver Cancer Risk in Patients With Hepatitis C
New generation of antiviral drugs cause significant reduction in the risk for the most common type of adult liver cancer in patients with HCV.
Weight Loss Intervention May Improve Type 2 Diabetes Management
Web-based weight loss intervention shows promise addressing obesity in patients with type 2 diabetes.
3 Unconventional Must-Read Books This Summer
Here are 3 books that will help make you a better pharmacist.
5 Things You Should Know About Hand, Foot, and Mouth Disease
Hand, foot, and mouth disease (HFMD) is a contagious viral infection common in infants and young children.
Methotrexate, Obesity, and Ectopic Pregnancy
Should methotrexate dosing be adjusted or capped in morbidly obese patients?
5 Tips for Finding a New Pharmacy Job While You're Still Employed
It’s human nature to lose focus on your existing job when you begin searching for a new one.
Traveling Internationally This Summer? Be Sure to Get the MMR Vaccine
Summer is a popular time to travel, but it is especially important to remind patients about measles outbreaks and prevention strategies.
Tramadol May Reduce Opioid Withdrawal Symptoms
Tramadol extended-release could address the growing problem of opioid misuse disorder.
Integration of Pharmacy, Medical Benefits May Improve Specialty Drug Management
Large group employers report significant cost challenges associated with specialty drugs.
Specialty Drugs Provide Financial Challenges for Employers
Integrating medical and pharmacy benefits may better inform employer management of specialty drugs.
Cancer Peptide Vaccine Receives FDA Orphan Drug Designation
Novel drug may increase immune system attack against cancer cells in patients with myelodysplastic syndrome.
Novel Vaccine for Myelodysplastic Syndrome Granted Orphan Drug Designation
One-third of patients with myelodysplastic syndrome progress to acute myeloid leukemia.
Breast Cancer Biosimilar Demonstrates Equivalent Efficacy to Trastuzumab
Investigational biosimilar to Herceptin is designed to treat HER2-positive early breast cancer.
